EVO301
搜索文档
Evommune (NYSE:EVMN) Earnings Call Presentation
2025-12-12 05:00
Corporate Presentation December 2025 © Evommune, Inc. Disclaimers This presentation has been prepared by Evommune, Inc. ("we", "us" or "our") and contains forward-looking statements, including: statements about our expectations regarding the potential benefits, clinical activity and tolerability of our product candidates; our expectations with regard to the results of our clinical trials, preclinical studies and research and development programs, including the timing and availability of data from such trial ...